Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 21, 2024 07:00 ET | Source: CTT Pharmaceutical Holdings, Inc.

CTT Pharmaceuticals Holdings, Inc. Successfully Completes 2 Year PCAOB Audit

TAMPA, Fla., Aug. 21, 2024 (GLOBE NEWSWIRE) -- CTT Pharmaceuticals Holdings, Inc. (OTC: CTTH), is pleased to announce that the registered PCAOB Accounting Firm of DiPiazza, LaRocca, Heeter &...
July 19, 2019 16:38 ET | Source: CTT Pharmaceutical Holdings, Inc.

CTT Pharmaceutical Holdings, Inc. Provides Corporate Update

Hamilton, Ontario, July 19, 2019 (GLOBE NEWSWIRE) -- CTT Pharmaceutical Holdings, Inc., (“CTT”) (OTC:CTTH), an innovative life sciences company with a portfolio of IP in novel drug delivery systems,...
January 15, 2019 08:16 ET | Source: CTT Pharmaceutical Holdings, Inc.

CTT Pharmaceutical Holdings, Inc., (CTTH) Announces National Patent Applications Worldwide for Orally Administrable Nanonized Opioids, Cannabinoids, Nutraceuticals and Other Pharmaceutical Agents

Includes All Markets in which Aurora Cannabis Currently Operates or Contemplates Future Operations Hamilton, Ontario, Jan. 15, 2019 (GLOBE NEWSWIRE) -- CTT Pharmaceutical Holdings, Inc.,...
October 01, 2018 07:00 ET | Source: CTT Pharmaceutical Holdings, Inc.

CTT Pharmaceuticals Initiates Legal Action Against Rapid Dose Therapeutics Ltd.

Hamilton, Ontario, Oct. 01, 2018 (GLOBE NEWSWIRE) -- CTT Pharmaceutical Holdings Inc. ("CTT") (OTC: CTTH) announced today that it is seeking an injunction to restrain Rapid Dose Therapeutics Ltd....
September 11, 2018 10:08 ET | Source: CTT Pharmaceutical Holdings, Inc.

Aurora Cannabis Converts CTT Pharmaceuticals Debenture into 9% Equity Position

Companies Working on Regulatory Approval for CTT’s Sublingual Wafer Technology Hamilton, Ontario, Sept. 11, 2018 (GLOBE NEWSWIRE) -- CTT Pharmaceutical Holdings Inc. ("CTT") (OTC: CTTH)...
July 12, 2018 08:00 ET | Source: CTT Pharmaceutical Holdings, Inc.

CTT Pharmaceuticals Appoints Aurora Nominee Dr. Jason Dyck to Board of Directors

HAMILTON, Ontario, July 12, 2018 (GLOBE NEWSWIRE) -- CTT Pharmaceutical Holdings, Inc., (the “Company” or “CTT”) (OTC:CTTH), an innovative life sciences company with an extensive portfolio of IP in...
June 07, 2018 07:00 ET | Source: CTT Pharmaceutical Holdings, Inc.

CTT Pharmaceuticals Announces Executive Management Change

HAMILTON, Ontario, June 07, 2018 (GLOBE NEWSWIRE) -- CTT Pharmaceutical Holdings, Inc., (the “Company” or “CTT”) (OTC:CTTH), an innovative life sciences company with an extensive portfolio of IP in...
June 05, 2018 12:36 ET | Source: CTT Pharmaceutical Holdings, Inc.

CTT Pharmaceuticals Completes Strategic Investment with Aurora Cannabis Funds Earmarked for Expansion of Patent Portfolio

Hamilton, Ontario, June 05, 2018 (GLOBE NEWSWIRE) -- Further to the company’s press release of May 22, 2018, CTT Pharmaceutical Holdings Inc. ("CTT") (US-OTC: CTTH) announced today the completion...
May 22, 2018 07:31 ET | Source: CTT Pharmaceutical Holdings, Inc.

Aurora Cannabis Makes Strategic Investment in CTT Pharmaceutical

Aurora Expands Exclusive Access to CTT’s Product and Development Pipeline Edmonton, AB, May 22, 2018 (GLOBE NEWSWIRE) -- Aurora Cannabis Inc. (“Aurora” or the “Company”) (TSX: ACB) (OTCQB:...
May 15, 2018 06:33 ET | Source: CTT Pharmaceutical Holdings, Inc.

CTT Pharmaceutical Holdings, Inc. Provides Corporate Update with Emphasis on Patent Portfolio

HAMILTON, Ontario, May 15, 2018 (GLOBE NEWSWIRE) -- HAMILTON, Ontario, May 16 2018 (GLOBE NEWSWIRE)—CTT Pharmaceutical Holdings, Inc., (OTC:CTTH), an innovative life sciences company with an...